{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:07:21Z","timestamp":1778976441997,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1136\/ard.2006.059162","type":"journal-article","created":{"date-parts":[[2006,12,2]],"date-time":"2006-12-02T01:34:51Z","timestamp":1165023291000},"page":"945-951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis"],"prefix":"10.1016","volume":"66","author":[{"given":"J Y","family":"Reginster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Malmstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A T","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S P","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A S","family":"Reicin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2006.059162_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(05)71086-2","article-title":"Pathogenesis and management of pain in osteoarthritis","volume":"365","author":"Dieppe","year":"2005","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.059162_bib2","series-title":"Kelley\u2019s textbook of rheumatology","first-page":"1409","article-title":"Clinical features of osteoarthritis","author":"Solomon","year":"2001"},{"key":"10.1136\/ard.2006.059162_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/ard.55.9.659","article-title":"Occurrence of osteoarthritis of the peripheral joints in European populations","volume":"55","author":"Petersson","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2006.059162_bib4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.059162_bib5","first-page":"6","article-title":"NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal","volume":"28","author":"Fries","year":"1991","journal-title":"J Rheumatol Suppl"},{"key":"10.1136\/ard.2006.059162_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2006.059162_bib7","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.059162_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1358\/dot.2004.40.5.850488","article-title":"Etoricoxib","volume":"40","author":"Matsumoto","year":"2004","journal-title":"Drugs Today (Barc)"},{"key":"10.1136\/ard.2006.059162_bib9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.059162_bib10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2006.059162_bib11","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.105.595793","article-title":"Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events","volume":"113","author":"Chan","year":"2006","journal-title":"Circulation"},{"key":"10.1136\/ard.2006.059162_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0149-2918(04)90007-0","article-title":"Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials","volume":"26","author":"Curtis","year":"2004","journal-title":"Clin Ther"},{"key":"10.1136\/ard.2006.059162_bib13","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/41.9.1052","article-title":"Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis","volume":"41","author":"Gottesdiener","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.059162_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1185\/030079902125000282","article-title":"Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: a randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial","volume":"18","author":"Leung","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1136\/ard.2006.059162_bib15","first-page":"135","article-title":"Treatment with etoricoxib, a COX-2 selective inihibitor, resulted in clinical improvement in knee and hip osteoarthritis (OA) over 52 weeks [abstract]","volume":"44","author":"Fisher","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.059162_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/rheumatology\/keh102","article-title":"Osteoarthritis\u2014the impact of a serious disease","volume":"43","author":"Breedveld","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2006.059162_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/sarh.2002.37216","article-title":"Anti-inflammatory agents and renal function","volume":"32","author":"Brater","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2006.059162_bib18","first-page":"346","article-title":"Tolerability and effectiveness of etoricoxib compared to diclofenac sodium in patients with osteoarthritis: a randomized controlled study (EDGE trial)","volume":"50","author":"Baraf H S","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2006.059162_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1185\/030079905X43686","article-title":"The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis analysis,","volume":"21","author":"Ramey","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1136\/ard.2006.059162_bib20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1572-0241.2003.07598.x","article-title":"The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events","volume":"98","author":"Hunt","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1136\/ard.2006.059162_bib21","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1185\/030079906X148238","article-title":"Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective inhibitor etoricoxib","volume":"22","author":"Curtis","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1136\/ard.2006.059162_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)16894-3","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial","volume":"364","author":"Farkouh","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2006.059162_bib23","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724192394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724192394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2006.059162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T14:00:16Z","timestamp":1736085616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724192394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0003496724192394"],"URL":"https:\/\/doi.org\/10.1136\/ard.2006.059162","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2006.059162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Copyright 2007 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}